+499.5%
MRNA vs BTSG
+152.4%
+347.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BTSG | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.1% | -1.1% | -2.0% |
| 7D | +5.5% | +2.7% | +2.8% | +4.8% |
| 30D | +158.7% | -3.6% | +162.4% | +161.8% |
| 3M | +182.1% | +5.8% | +176.3% | +173.3% |
| 6M | +151.8% | +44.7% | +107.1% | +116.3% |
| YTD | +393.6% | +62.2% | +331.4% | +310.3% |
| 1Y | +499.5% | +152.1% | +347.4% | +351.1% |
| All | +499.5% | +152.4% | +347.1% | +351.1% |
Cumulative growth
Daily Returns
Daily percentage return beside BTSG.
Daily Out/Under-Performance
Portfolio return minus BTSG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BTSG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BTSG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling